Feedback / Questions
ACT-903 - Alpha Cancer Technologies
https://www.businesswire.com/news/home/20230531005356/en/Alpha-Cancer-Technologies-Presents-New-Data-from-ACT-903-an-AFP-Maytansine-Conjugate-in-Online-Publication-at-the-2023-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting
May 31, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next